[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334910-105":59,"doc-detail-334910-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multiomics-analysis-of-the-phlda-gene-family-in-different-cancers-and-their-clinical-prognostic-value","Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value","","The PHLDA (pleckstrin homology-like domain family) gene family is investigated as a potential biomarker for cancer detection and as a possible therapeutic target. Because the predictive significance of PHLDA genes across cancers remains unclear, a systematic multiomics workflow evaluates pleckstrin expression and survival associations using multiple online resources. Protein–protein interaction analysis identifies functional partners, while relationships with cancers are assessed through mutation and copy-number alterations. Cumulative effects are characterized using gene ontology (GO) and pathway analyses, revealing prognostic implications and candidate therapeutic roles for PHLDA1, PHLDA2, and PHLDA3 in distinct tumor types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multiomics-analysis-of-the-phlda-gene-family-in-different-cancers-and-their-clinical-prognostic-value/334910/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multiomics-analysis-of-the-phlda-gene-family-in-different-cancers-and-their-clinical-prognostic-value/334910.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the multiomics study on the PHLDA gene family?","Question",{"text":112,"@type":113},"To clarify the role of pleckstrin/PHLDA genes as prognostic biomarkers by using a systematic multiomics approach across human cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are pleckstrin/PHLDA expression and prognostic significance evaluated?",{"text":117,"@type":113},"The study uses various survival analyses and online platforms to assess pleckstrin expression and predictive significance in human tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"What additional analyses are performed beyond expression and survival associations?",{"text":121,"@type":113},"Protein–protein interaction analysis is used to select functional protein partners, and mutation and copy number alterations are analyzed alongside GO and pathway analyses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334910,1790252271,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Article  \nMultiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value  \nSafia Iqbal 1,†, Md. Rezaul Karim 1,†, Shahnawaz Mohammad 2, Ramya Mathiyalagan 2, Md. Niaj Morshed 1, Deok-Chun Yang 1,3, Hyocheol Bae 3, Esrat Jahan Rupa 4, * and Dong Uk Yang 1, *  \nCitation: Iqbal, S.; Karim, M.R.; Mohammad, S.; Mathiyalagan, R.; Morshed, M.N.; Yang, D.-C.; Bae, H.; Rupa, E.J.; Yang, D.U. Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value. Curr. Issues Mol. Biol. 2024, 46, 5488–5510. [https://](https://)[ ](https://)[doi.org/10.3390/cimb46060328](doi.org/10.3390/cimb46060328)  \nAcademic Editor: Giulia Fiscon  \nReceived: 14 April 2024  \nRevised: 21 May 2024  \nAccepted: 23 May 2024  \nPublished: 30 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Biopharmaceutical Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of Korea; [safiadorin@khu.ac.kr](safiadorin@khu.ac.kr) (S.I.); [rezaulshimul@khu.ac.kr](rezaulshimul@khu.ac.kr) (M.R.K.); [niajmorshed96@khu.ac.kr](niajmorshed96@khu.ac.kr) (M.N.M.); [dcyang@khu.ac.kr](dcyang@khu.ac.kr) (D.-C.Y.)  \n2 Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of Korea; [shnwzmohd@yahoo.com](shnwzmohd@yahoo.com) (S.M.); [ramyabinfo@gmail.com](ramyabinfo@gmail.com) (R.M.)  \n3 Department of Oriental Medicinal Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Gyeonggi-do, Republic of Korea; [bhc7@khu.ac.kr](bhc7@khu.ac.kr)  \n4 College of Korean Medicine, Woosuk University, Wanju-gun 55338, Jeollabuk-do, Republic of Korea  \n* Correspondence: [eshratrupa91@gmail.com](eshratrupa91@gmail.com) (E.J.R.); [dongukyang83@gmail.com](dongukyang83@gmail.com) (D.U.Y.)† These authors contributed equally to this work.  \nAbstract: The PHLDA (pleckstrin homology-like domain family) gene family is popularly known as a potential biomarker for cancer identification, and members of the PHLDA family have become considered potentially viable targets for cancer treatments. The PHLDA gene family consists of PHLDA1, PHLDA2, and PHLDA3 . The predictive significance of PHLDA genes in cancer remains unclear. To determine the role of pleckstrin as a prognostic biomarker inhuman cancers, we conducted a systematic multiomics investigation. Through various survival analyses, pleckstrin expression was evaluated, and their predictive significance in human tumors was discovered using a variety of online platforms. By analyzing the protein–protein interactions, we also chose a collection of well-known functional protein partners for pleckstrin. Investigations were also carried out on the relationship between pleckstrins and other cancers regarding mutations and copy number alterations. The cumulative impact of pleckstrin and their associated genes on various cancers, Gene Ontology (GO), and pathway analyses were used for their evaluation. Thus, the expression profiles of PHLDA family members and their prognosis in various cancers may be revealed by this study. During this multiomics analysis, we found that among the PHLDA family, PHLDA1 may be a therapeutic target for several cancers, including kidney, colon, and brain cancer, while PHLDA2 can be a therapeutic target for cancers of the colon, esophagus, and pancreas. Additionally, PHLDA3 may be a useful therapeutic target for ovarian, renal, and gastric cancer.  \nKeywords: multiomics; PHLDA (pleckstrin homology-like domain family) gene; cancer biomarker; gene ontology (GO); gene pathway  \n1. Introduction  \nOne of the main cau","cbCaipk6Y8HpijSF","https://ap.wps.com/l/cbCaipk6Y8HpijSF","pdf",5148063,23,"English","# Introduction\n# Multiomics analysis and survival evaluation\n# Protein–protein interaction and functional partner selection\n# Mutation and copy number assessment across cancers\n# Gene ontology (GO) and pathway analyses\n# Prognostic findings and candidate therapeutic targets","[{\"question\":\"What is the main goal of the multiomics study on the PHLDA gene family?\",\"answer\":\"To clarify the role of pleckstrin/PHLDA genes as prognostic biomarkers by using a systematic multiomics approach across human cancers.\"},{\"question\":\"How are pleckstrin/PHLDA expression and prognostic significance evaluated?\",\"answer\":\"The study uses various survival analyses and online platforms to assess pleckstrin expression and predictive significance in human tumors.\"},{\"question\":\"What additional analyses are performed beyond expression and survival associations?\",\"answer\":\"Protein–protein interaction analysis is used to select functional protein partners, and mutation and copy number alterations are analyzed alongside GO and pathway analyses.\"}]","Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value | PDF",1790008799,58]